- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Zefer takes consulting skills into healthcare arena
Internet consulting and services firm Zefer has formed a new division that will concentrate exclusively on healthcare, including the pharmaceutical and managed-care markets. Zefer's Healthcare and Life Sciences practice will consult with
Internet consulting and services firm Zefer has formed a new division that will concentrate exclusively on healthcare, including the pharmaceutical and managed-care markets. Zefer's Healthcare and Life Sciences practice will consult with clients on the creation, development, and implementation of Internet-based business models. The three major areas of expertise include supply-chain management, customer relations management, and HIPAA compliance. While Zefer has worked with healthcare clients, the firm did not previously have a group dedicated to this industry.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 3.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
